Verified Clinical Trials, a clinical trial matching service, is in the second round of its sale process, two sources tell Axios Pro. Initial bids came in between $200 million and $300 million.
Why it matters: Trial recruitment is an expensive bottleneck for drug development that has drawn significant investor interest.
